cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Absci Corporation
7 own
5 watching
Current Price
$5.38
$-0.05
(-0.92%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
462.93M
52-Week High
52-Week High
6.72000
52-Week Low
52-Week Low
1.11100
Average Volume
Average Volume
1.34M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization462.93M
icon52-Week High6.72000
icon52-Week Low1.11100
iconAverage Volume1.34M
iconDividend Yield--
iconP/E Ratio--
What does the Absci Corporation do?
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Read More
How much money does Absci Corporation make?
News & Events about Absci Corporation.
Globe Newswire
1 year ago
VANCOUVER, Wash. and NEW YORK, April 06, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 22nd Annual Needham Virtual Healthcare Conference. Absci management is scheduled to present on ...
Globe Newswire
1 year ago
VANCOUVER, Wash. and NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating virtually in the upcoming B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the ...
Globe Newswire
1 year ago
VANCOUVER, Wash. and NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 43rd Annual Cowen Health Care Conference. Abscis management is scheduled to participate in a ...
Globe Newswire
1 year ago
Abscis generative AI and wet lab capabilities combined with St. Johns Cancer Institutes molecular database of cancer patient specimens will accelerate the development of immunotherapies. VANCOUVER, Wash. and NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative ...
Globe Newswire
1 year ago
In silico antibody design expert Dr. Victor Greiff, synthetic biology pioneer Dr. Timothy Lu, and translational medicine veteran Dr. Hubert Truebel will strengthen Abscis scientific leadership in biologic drug creation.VANCOUVER, Wash. and NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Absci ...
Frequently Asked Questions
Frequently Asked Questions
What is Absci Corporation share price today?
plus_minus_icon
Can Indians buy Absci Corporation shares?
plus_minus_icon
How can I buy Absci Corporation shares from India?
plus_minus_icon
Can Fractional shares of Absci Corporation be purchased?
plus_minus_icon
What are the documents required to start investing in Absci Corporation stocks?
plus_minus_icon
What is today’s traded volume of Absci Corporation?
plus_minus_icon
What is today’s market capitalisation of Absci Corporation?
plus_minus_icon
What is the 52-Week High and Low Range of Absci Corporation?
plus_minus_icon
What percentage is Absci Corporation down from its 52-Week High?
plus_minus_icon
What percentage is Absci Corporation up from its 52-Week Low?
plus_minus_icon
Current Price
$5.38
$-0.05
(-0.92%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00